PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
23620484-6	2013	Notably, both BCRP and MDR1 conferred resistance to AR-67 lactone.	7-tert-butyldimethylsilyl-10-hydroxycamptothecin	52-57	ATP binding cassette subfamily G member 2 (Junior blood group)	Mus musculus	14-18
31292985-10	2019	AR-67 in the SBE-beta-CD formulation exhibited dose linearity following both oral and intravenous administration.	7-tert-butyldimethylsilyl-10-hydroxycamptothecin	0-5	beta-carotene oxygenase 1	Mus musculus	17-24
23620484-6	2013	Notably, both BCRP and MDR1 conferred resistance to AR-67 lactone.	7-tert-butyldimethylsilyl-10-hydroxycamptothecin	52-57	ATP-binding cassette, sub-family B (MDR/TAP), member 1B	Mus musculus	23-27
17896945-7	2007	The relative affinities of hydroxycamptothecins to HSA and model membranes in the form of DMPC liposomes were determined, and DB-67 exhibited the most desirable properties including the highest affinity to membranes in its lactone form and low affinity to HSA in its carboxylate form.	7-tert-butyldimethylsilyl-10-hydroxycamptothecin	126-131	albumin	Homo sapiens	51-54
17896945-7	2007	The relative affinities of hydroxycamptothecins to HSA and model membranes in the form of DMPC liposomes were determined, and DB-67 exhibited the most desirable properties including the highest affinity to membranes in its lactone form and low affinity to HSA in its carboxylate form.	7-tert-butyldimethylsilyl-10-hydroxycamptothecin	126-131	albumin	Homo sapiens	256-259